ANGO vs JAZZ · rev $292.5M vs P/E 1988, rev $4.07B
AngioDynamics Inc (ANGO) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
ANGO currently screens at market cap $378.5M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the ANGO and JAZZ stock pages for the full models.
Not investment advice.